Check Claims Before You Publish

 Quick Explanation Copied

 Long Explanation

Citation Profile and Impact

McMann's citation metrics indicate an early-career researcher whose impact is concentrated almost entirely in one high-impact collaborative paper. Her 2022 Cancer Discovery study on Clostridioides difficile-driven tumorigenesis has accumulated 141 of her ~206–260 total citations — roughly 55–68% of her lifetime total Cancer Discovery C. difficile tumorigenesis paper. A second strong paper, comparing colon-cancer-derived Fusobacterium nucleatum subspecies in murine models, has 60 citations mBio Fusobacterium subspecies paper, and a 2025 npj Biofilms and Microbiomes paper confirming F. nucleatum enrichment in invasive CRC biofilms has 51 citations npj Biofilms F. nucleatum biofilm paper.

Note the 2023 gap and absence of 2024/2026 records in OpenAlex, which signal incomplete indexing rather than necessarily zero activity — a known limitation of bibliometric databases.

Research Focus and Scientific Contribution

Her topical profile is tightly coherent: colorectal cancer, microbiome, and cancer biology OpenAlex author profile. She contributed to a sustained Johns Hopkins research program characterizing procarcinogenic bacteria: biofilm epidemiology in screening colonoscopy cohorts Gut Microbes biofilm epidemiology paper, and immune-microenvironment work showing fusobacteria associate with Th1/Th17 responses in colon cancer patients and germ-free mice FASEB Th1/Th17 fusobacteria abstract.

Strengths, Weaknesses, and Blind Spots

Strengths: Publication in top-tier venues (Cancer Discovery, mBio, Gut Microbes, npj Biofilms and Microbiomes) within a rigorous, mechanistically deep murine-gnotobiotic program; consistent open-access practices (12 of 14 works in 2023 were OA); clear thematic specialization in a high-impact niche (microbiome–CRC carcinogenesis).

Weaknesses and uncertainties: Nearly all positions are middle authorship — the record shows no first- or last-author flagship papers, making independent scientific leadership unestablished. The h-index discrepancy (5 in the provided Semantic Scholar-style data vs 3 in OpenAlex) illustrates the fragility of bibliometric inference; OpenAlex shows zero citations recorded in 2023 for a 14-paper year, likely reflecting indexing lag, not quality. Several records are conference abstracts with ~1–2 citations, which inflate paper counts without peer-reviewed substance. Critically, her most-cited work is a shared group achievement whose citation credit flows substantially to senior authors, so per-author impact is likely overstated by aggregate counts — a known limitation of whole-paper citation attribution.

Verdict on confidence: Moderate confidence overall; the citation data are consistent across two databases on totals (~206–260) and the flagship paper, but per-author contribution cannot be disentangled from author-order metadata alone.

 BGPT Author Review

Scientific Quality

Early-career researcher with a coherent, mechanistically interesting microbiome–colorectal cancer portfolio published in strong venues, but nearly all contributions are middle-author; no first/last-author flagship work; ~141 of ~260 citations derive from a single collaborative 2022 Cancer Discovery paper. Productive but not yet demonstrated independent scientific leadership.

Communication Quality

Papers appear in well-edited, high-visibility journals with clear abstracts and mechanistic framing; however, no evidence of independent communication platform (reviews, preprints with narrative leadership, or sole-authored work) is available from the record.

Author Novelty

The C. difficile tumorigenesis work was genuinely novel — establishing a previously underappreciated bacterium as a colorectal cancer driver — while the colonoscopy-cohort biofilm and risk-factor abstracts are more incremental and descriptive.

Scientific Rigor

The flagship work used controlled germ-free ApcMin/+ mouse reassociation experiments with isogenic toxin mutants — a strong causal design — and the subspecies comparison integrated WGS with phenotyping. Rigor cannot be independently assessed for her specific contributions given middle authorship.